Below are the financial statements of MetLife, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
All figures in billions of USD | 2024 | 2023 |
---|---|---|
Investments | — | — |
Fixed maturity securities available-for-sale, at estimated fair value (net of allowance for credit loss of $160 and $184, respectively); and amortized cost: $307,421 and $300,555, respectively | 281.04a | 281.41a |
Equity securities, at estimated fair value | 0.71a | 0.76a |
Contractholder-directed equity securities and fair value option securities, at estimated fair value | 10.67a | 10.33a |
Mortgage loans (net of allowance for credit loss of $800 and $721, respectively) | 89.01a | 92.51a |
Policy loans | 8.55a | 8.79a |
Real estate and real estate joint ventures (includes $378 and $317, respectively, under the fair value option; $65 and $0, respectively, of real estate held-for-sale; $183 and $0, respectively, relating to variable interest entities) | 13.34a | 13.33a |
Other limited partnership interests | 14.38a | 14.76a |
Short-term investments, principally at estimated fair value | 5.16a | 6.05a |
Other invested assets (net of allowance for credit loss of $0 and $23, respectively; includes $1,851 and $1,993, respectively, of leveraged and direct financing leases; $424 and $333, respectively, relating to variable interest entities) | 18.5a | 18.2a |
Total investments | 441.36a | 446.14a |
Assets | — | — |
Cash and cash equivalents, principally at estimated fair value | 20.07a | 20.64a |
Accrued investment income | 3.49a | 3.59a |
Premiums, reinsurance and other receivables (includes $47 and $0, respectively, relating to variable interest entities) | 29.76a | 28.97a |
Market risk benefits, at estimated fair value | 0.37a | 0.29a |
Deferred policy acquisition costs and value of business acquired | 19.63a | 20.15a |
Current income tax recoverable | 0.3a | 0.19a |
Deferred income tax asset | 2.99a | 2.61a |
Goodwill | 8.9a | 9.24a |
Other assets | 11.08a | 11.14a |
Separate account assets | 139.5a | 144.63a |
Total assets | 677.46a | 687.58a |
Liabilities | — | — |
Future policy benefits | 193.65a | 196.41a |
Policyholder account balances | 221.45a | 219.27a |
Market risk benefits, at estimated fair value | 2.58a | 3.18a |
Other policy-related balances | 18.9a | 19.74a |
Policyholder dividends payable | 0.39a | 0.39a |
Payables for collateral under securities loaned and other transactions | 17.13a | 17.52a |
Short-term debt (includes $133 and $0, respectively, relating to variable interest entities) | 0.47a | 0.12a |
Long-term debt | 15.09a | 15.55a |
Collateral financing arrangement | 0.48a | 0.64a |
Junior subordinated debt securities | 3.16a | 3.16a |
Deferred income tax liability | 0.13a | 0.93a |
Other liabilities | 36.84a | 35.81a |
Separate account liabilities | 139.5a | 144.63a |
Total liabilities | 649.75a | 657.33a |
MetLife, Inc.’s stockholders’ equity | — | — |
Preferred stock | 0a | 0a |
Common stock | 0.01a | 0.01a |
Additional paid-in capital | 33.79a | 33.69a |
Retained earnings | 42.63a | 40.15a |
Treasury stock, at cost | -27.8a | -24.59a |
Accumulated other comprehensive income (loss) | -21.19a | -19.24a |
Equity | — | — |
Total MetLife, Inc.’s stockholders’ equity | 27.45a | 30.02a |
Noncontrolling interests | 0.26a | 0.24a |
Total equity | 27.7a | 30.25a |
Total liabilities and equity | 677.46a | 687.58a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore MetLife’s data sources below and access millions more through our Disclosure Search.